Stay up to date with the latest breaking news, analysis and commentary on Mirae Asset Sharekhan. Find live updates, exchanges, stock news, earning news and more.
OneSource Specialty Pharma announced a strategic manufacturing partnership for biosimilars.
Under the partnership, OneSource will serve as a strategic manufacturing partner for Formycon and provide integrated Drug Substance (DS) and Drug Product (DP) manufacturing capabilities from its state-of-the-art biologics’ facility in Bangalore. The collaboration brings together Formycon´s Biosimilar development excellence with OneSource's end-to-end biologics manufacturing expertise to support Formycon's biosimilar programs for global markets.
The partnership reflects the shared commitment of both companies to advancing global access to biosimilars through reliable, high-quality, and scalable manufacturing. Achieving this requires not only scientific excellence but also a sustainable, cost-effective manufacturing model — that OneSource is specifically positioned to deliver.
At 12.01 pm, OneSource Specialty Pharma was trading at Rs. 1,633.75, down by 2.27%, with a volume of 2147 shares on the BSE.
Apollo Micro bags order worth Rs. 134 cr from DRDO, Indian Navy, Defence PSUs, State Govt & Pvt Industries
15 Jul 2026, 3:04PMAnupam Rasayan signs Letter of Intent with BASQUEVOLT, S.A. for the potential long-term supply of a specialty chemical product worth $300 Mn
15 Jul 2026, 11:50AML&T wins order for Power Transmission & Distribution Business in Saudi Arabia
29-10-2025 10:13:15The ePlane Company signs MOU with Ramco Systems
27-10-2025 12:42:39Refex Industries gets an order worth Rs. 300 Cr from a mining entity in Jharkhand
24-10-2025 13:57:18Diwali Stocks Picks 2025
